NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/19/2026
Back to search
Official data from USPTO
ACCUTRIC-002
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ACCUTRIC-002
ST13
US500000098589565Class
5, 42
Filing
98589565
Registration
8258665
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
05/19/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 42
Filing date
06/06/2024
Registration date
05/19/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/19/2026
Last transaction
05/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Vancouver, BC, CA
Examiner
SHEN, DANIEL HOWE
Law office
O10
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
DEFENCE THERAPEUTICS INC.
Representatives
Bradley L. Cohn Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Radiopharmaceutical drug delivery agent in the form of an intracellular and nuclear enhancer; radiopharmaceutical theranostic delivery agent in the form of an intracellular and nuclear enhancer; radiopharmaceutical imaging delivery agent in the form of an intracellular and nuclear enhancer; medicinal preparations for use in oncology; pharmaceutical radio-immuno-conjugate (radiolabeled antibody) preparations for the treatmentdiagnosis and theranosis of cancer; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for human useimmunotherapies for the treatment of cancer; pharmaceutical preparations for human usepharmaceutical radiolabeled antibodies for the treatmentdiagnosis and theranosis of cancerrespiratory diseasesauto-immune diseasesfor the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human usepharmaceutical antibodies for use as anti-infectivesfor use as anti-inflammatories; radio-immuno-conjugates for treating cancer; vaccines for human use
Class 42
Antibody profiling for scientific research purposes; research and development of vaccines and medicines; scientific research for medical purposes in the field of immunotherapy; scientific research for medical purposes in the field of oncology
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/19/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/31/2026
PUBO
PUBLISHED FOR OPPOSITION
03/31/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/25/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/04/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/04/2026
ALIE
ASSIGNED TO LIE
02/04/2026
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/28/2026
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
12/08/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
12/08/2025
CNSI
SUSPENSION INQUIRY WRITTEN
12/08/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/30/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/30/2024
GNSL
LETTER OF SUSPENSION E-MAILED
12/30/2024
CNSL
SUSPENSION LETTER WRITTEN
12/30/2024
DOCK
ASSIGNED TO EXAMINER
12/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/19/2024
NWAP
NEW APPLICATION ENTERED
06/07/2024
Continuous trademark protection
Get notified about every new filing that threatens ACCUTRIC-002 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.